News
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Skyclarys is an important growth product for Biogen, which has been hit in the last few years by a series of pipeline ...
Local talent, writer/filmmaker John McCarty, has published many film books and a few mystery novels over the years. He also ...
Derek spent his brief but incandescent life in Princeton where he served as a center of gravity for the entire community.
4don MSN
From facial paralysis to ringing sensation in the ear to progressive vision loss, know the early warning signs of brain ...
A new study reveals that mitochondrial dysfunction plays a central role in the loss of Purkinje neurons in the cerebellum, ...
When people with multiple pets get home to find something unexpected, missing or destroyed, they often don't know which furry ...
3d
News Medical on MSNLink found between mitochondria and MS brain damageMS is marked by chronic inflammation and demyelination in the central nervous system. Demyelination is the process in which ...
6d
Bob & Brad on MSNHow Is Bob Doing? What Has Helped?This article is a transcribed, edited summary of a video Bob and Brad recorded in May of 2024. For the original video, go to ...
Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results